"Boston Children's in Boston, MA has always embodied a culture of innovation and scientific discovery, with the goal of improving the lives of children and families. This legacy continues today as we lead the world in pediatric research, empowering our clinicians and scientists to challenge the status quo and seek better answers for children everywhere."

During the past decade, Boston Children's Hospital: Department of Immunology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Boston Children's Hospital: Department of Immunology" #1 collaborator was "Childhood Asthma in Urban Settings (CAUSE)" with 1 trials as a collaborator, "Regeneron Pharmaceuticals" with 1 trials as a collaborator and "Rho Federal Systems Division, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Boston Children's Hospital: Department of Immunology" are "Asthma" (2 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Boston Children's Hospital: Department of Immunology" in a lesser frequency.

Most popular intervention types in "Boston Children's Hospital: Department of Immunology" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dupilumab" (2 trials), "Placebo" (1 trials), "Triamcinolone Acetonide" (1 trials) and "Vanicream" (1 trials). Other intervention names were less common.

The vast majority of trials in "Boston Children's Hospital: Department of Immunology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Boston Children's Hospital: Department of Immunology". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Boston Children's Hospital: Department of Immunology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Boston Children's Hospital: Department of Immunology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".